By www.reliablebusinessinsights.com
Global And United States Restless Legs Syndrome Market Report & Forecast 2024-2031 Story
92
$ 4350
Restless Legs Syndrome Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
GlaxoSmithKline plc. Ligand Pharmaceuticals Incorporated axxonis Pharma AG Kyowa Hakko Kirin Jazz Pharmaceuticals Omeros Corporation Manhattan Pharmaceuticals Boehringer Ingelheim GmbH UCB SA